From Cell Culture to Populations: Evidence that a group of pain-relievers slow Alzheimer’s disease progression

New research has come out showing that a group of nonsteroidal anti-inflammatory drugs (NSAID) may have therapeutic effects for Alzheimer’s Disease.

Dr Jack Rivers-Auty and his team have been investigating the impact of nonsteroidal anti-inflammatory drugs (NSAIDs) in reducing neuroinflammation.

Using mice models Jack and his team have found that the use of NSAIDs (specifically mefenamic acid) was effective in improving memory and reducing neuroinflammation in affected mice. Additionally, in a separate study Jack and his team found that the use of NSAIDs (dicofenac) was associated with slower cognitive decline in a sample of individuals from the Alzheimer’s Disease Neuroimaging Initiative.

Click here for a link to the article.

Listen to Jack talk about his work here.